{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:23:03Z","timestamp":1772166183450,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-025-03697-2","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T03:29:21Z","timestamp":1738726161000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating the risk of underdiagnosis of invasive breast cancer in needle biopsy-diagnosed ductal carcinoma in situ eligible for radiofrequency ablation"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9393-9655","authenticated-orcid":false,"given":"Hideo","family":"Shigematsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mutsumi","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanako","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruka","family":"Ikejiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai","family":"Amioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emiko","family":"Hiraoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinsuke","family":"Sasada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Arihiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morihito","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,5]]},"reference":[{"key":"3697_CR1","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s10549-012-1975-y","volume":"133","author":"JA Glover","year":"2012","unstructured":"Glover JA, Bannon FJ, Hughes CM, Cantwell MM, Comber H, Gavin A, Deady S, Murray LJ. Increased diagnosis and detection rates of carcinoma in situ of the breast. Breast Cancer Res Treat. 2012;133:779\u201384.","journal-title":"Breast Cancer Res Treat"},{"key":"3697_CR2","doi-asserted-by":"crossref","unstructured":"Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L, Force USPST: Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med. 2009;151:727\u2013737, W237\u2013742.","DOI":"10.7326\/0003-4819-151-10-200911170-00009"},{"key":"3697_CR3","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1016\/S0140-6736(05)67887-7","volume":"366","author":"M Clarke","year":"2005","unstructured":"Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans V, Godwin J, Gray R, Hicks C, James S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366:2087\u2013106.","journal-title":"Lancet"},{"key":"3697_CR4","first-page":"6","volume":"3","author":"AD Morris","year":"1997","unstructured":"Morris AD, Morris RD, Wilson JF, White J, Steinberg S, Okunieff P, Arriagada R, Le MG, Blichert-Toft M, van Dongen JA. Breast-conserving therapy vs mastectomy in early-stage breast cancer: a meta-analysis of 10-year survival. Cancer J Sci Am. 1997;3:6\u201312.","journal-title":"Cancer J Sci Am"},{"key":"3697_CR5","doi-asserted-by":"crossref","unstructured":"Hau E, Browne L, Capp A, Delaney GP, Fox C, Kearsley JH, Millar E, Nasser EH, Papadatos G, Graham PH: The impact of breast cosmetic and functional outcomes on quality of life: long-term results from the St. George and Wollongong randomized breast boost trial. Breast Cancer Res Treat .2013;139:115\u2013123.","DOI":"10.1007\/s10549-013-2508-z"},{"key":"3697_CR6","doi-asserted-by":"publisher","first-page":"5525","DOI":"10.1245\/s10434-021-10501-4","volume":"28","author":"RE Fine","year":"2021","unstructured":"Fine RE, Gilmore RC, Dietz JR, Boolbol SK, Berry MP, Han LK, Kenler AS, Sabel M, Tomkovich KR, VanderWalde NA, et al. Cryoablation Without Excision for Low-Risk Early-Stage Breast Cancer: 3-Year Interim Analysis of Ipsilateral Breast Tumor Recurrence in the ICE3 Trial. Ann Surg Oncol. 2021;28:5525\u201334.","journal-title":"Ann Surg Oncol"},{"key":"3697_CR7","first-page":"505","volume":"6","author":"S Takayama","year":"2023","unstructured":"Takayama S, Kinoshita T, Shiino S, Jimbo K, Watanabe KI, Fujisawa T, Yamamoto N, Onishi T, Shien T, Ito M, et al. Patients Offer Radiofrequency Ablation Therapy for Early Breast Cancer as Local Therapy (PO-RAFAELO) Study under the Patient-proposed Health Services. JMA J. 2023;6:505\u201312.","journal-title":"JMA J"},{"key":"3697_CR8","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.ejso.2010.09.012","volume":"36","author":"Z Zhao","year":"2010","unstructured":"Zhao Z, Wu F. Minimally-invasive thermal ablation of early-stage breast cancer: a systemic review. Eur J Surg Oncol. 2010;36:1149\u201355.","journal-title":"Eur J Surg Oncol"},{"key":"3697_CR9","doi-asserted-by":"publisher","first-page":"e715","DOI":"10.1016\/j.clbc.2021.03.004","volume":"21","author":"EMF van de Voort","year":"2021","unstructured":"van de Voort EMF, Struik GM, Birnie E, Moelker A, Verhoef C, Klem T. Thermal Ablation as an Alternative for Surgical Resection of Small (<\/= 2 cm) Breast Cancers: A Meta-Analysis. Clin Breast Cancer. 2021;21:e715\u201330.","journal-title":"Clin Breast Cancer"},{"key":"3697_CR10","doi-asserted-by":"publisher","unstructured":"Zulkifli D, Abdul Manan H, Yahya N, Abdul Hamid H. The Applications of High-Intensity Focused Ultrasound (HIFU) Ablative Therapy in the Treatment of Primary Breast Cancer: A Systematic Review. Diagnostics (Basel). 2023;13(15):2595. https:\/\/doi.org\/10.3390\/diagnostics13152595.","DOI":"10.3390\/diagnostics13152595"},{"key":"3697_CR11","doi-asserted-by":"publisher","unstructured":"Kinoshita T, Takayama S, Takahashi M, Fujisawa T, Yamamoto N, Shien T, Futamura M, Ito M, Takahashi M, Aogi K, Watanabe K, Onishi T, Yoshida M, Tsuda H, Shibata T, Yorikane E, Ohata K. Radiofrequency ablation without excision for breast cancer: 5-year results of ipsilateral breast tumor recurrence-free survival in the RAFAELO study (NCCH1409). J Clin Oncol. 2024;42(16_suppl):578. https:\/\/doi.org\/10.1200\/JCO.2024.42.16_suppl.578.","DOI":"10.1200\/JCO.2024.42.16_suppl.578"},{"key":"3697_CR12","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1148\/radiol.11102368","volume":"260","author":"ME Brennan","year":"2011","unstructured":"Brennan ME, Turner RM, Ciatto S, Marinovich ML, French JR, Macaskill P, Houssami N. Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer. Radiology. 2011;260:119\u201328.","journal-title":"Radiology"},{"key":"3697_CR13","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.annonc.2023.08.017","volume":"34","author":"G Curigliano","year":"2023","unstructured":"Curigliano G, Burstein HJ, Gnant M, Loibl S, Cameron D, Regan MM, Denkert C, Poortmans P, Weber WP, Thurlimann B. St Gallen Consensus Conference P: Understanding breast cancer complexity to improve patient outcomes: The St Gallen International Consensus Conference for the Primary Therapy of Individuals with Early Breast Cancer 2023. Ann Oncol. 2023;34:970\u201386.","journal-title":"Ann Oncol"},{"key":"3697_CR14","doi-asserted-by":"crossref","unstructured":"Chavez de Paz Villanueva C, Bonev V, Senthil M, Solomon N, Reeves ME, Garberoglio CA, Namm JP, Lum SS: Factors Associated With Underestimation of Invasive Cancer in Patients With Ductal Carcinoma In Situ: Precautions for Active Surveillance. JAMA Surg 2017, 152:1007\u20131014.","DOI":"10.1001\/jamasurg.2017.2181"},{"key":"3697_CR15","doi-asserted-by":"crossref","unstructured":"Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR, Winchester DP: The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more \"personalized\" approach to cancer staging. CA Cancer J Clin. 2017;67:93\u201399.","DOI":"10.3322\/caac.21388"},{"key":"3697_CR16","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1200\/JCO.19.02309","volume":"38","author":"KH Allison","year":"2020","unstructured":"Allison KH, Hammond MEH, Dowsett M, McKernin SE, Carey LA, Fitzgibbons PL, Hayes DF, Lakhani SR, Chavez-MacGregor M, Perlmutter J, et al. Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO\/CAP Guideline Update. J Clin Oncol. 2020;38:1346\u201366.","journal-title":"J Clin Oncol"},{"key":"3697_CR17","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1200\/JCO.2018.77.8738","volume":"36","author":"AC Wolff","year":"2018","unstructured":"Wolff AC, Hammond MEH, Allison KH, Harvey BE, Mangu PB, Bartlett JMS, Bilous M, Ellis IO, Fitzgibbons P, Hanna W, et al. Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology\/College of American Pathologists Clinical Practice Guideline Focused Update. J Clin Oncol. 2018;36:2105\u201322.","journal-title":"J Clin Oncol"},{"key":"3697_CR18","doi-asserted-by":"crossref","unstructured":"Consensus Conference on the classification of ductal carcinoma in situ. The Consensus Conference Committee. Cancer. 1997;80:1798\u20131802.","DOI":"10.1002\/(SICI)1097-0142(19971101)80:9<1798::AID-CNCR15>3.0.CO;2-0"},{"key":"3697_CR19","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1186\/s12885-015-1479-3","volume":"15","author":"S Borgquist","year":"2015","unstructured":"Borgquist S, Zhou W, Jirstrom K, Amini RM, Sollie T, Sorlie T, Blomqvist C, Butt S, Warnberg F. The prognostic role of HER2 expression in ductal breast carcinoma in situ (DCIS); a population-based cohort study. BMC Cancer. 2015;15:468.","journal-title":"BMC Cancer"},{"key":"3697_CR20","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1093\/jjco\/hyab082","volume":"51","author":"N Iwamoto","year":"2021","unstructured":"Iwamoto N, Nara M, Horiguchi SI, Aruga T. Surgical upstaging rates in patients meeting the eligibility for active surveillance trials. Jpn J Clin Oncol. 2021;51:1219\u201324.","journal-title":"Jpn J Clin Oncol"},{"key":"3697_CR21","doi-asserted-by":"publisher","first-page":"7069","DOI":"10.1245\/s10434-023-13929-y","volume":"30","author":"CJC Meurs","year":"2023","unstructured":"Meurs CJC, van Bekkum S, van Rosmalen J, Menke-Pluijmers MBE, Siesling S, Westenend PJ. Validation and Clinical Utility of a Prediction Model for the Risk of Upstaging to Invasive Breast Cancer After a Biopsy Diagnosis Ductal Carcinoma In Situ. Ann Surg Oncol. 2023;30:7069\u201380.","journal-title":"Ann Surg Oncol"},{"key":"3697_CR22","doi-asserted-by":"crossref","unstructured":"Jakub JW, Murphy BL, Gonzalez AB, Conners AL, Henrichsen TL, Maimone St, Keeney MG, McLaughlin SA, Pockaj BA, Chen B, et al. A Validated Nomogram to Predict Upstaging of Ductal Carcinoma in Situ to Invasive Disease. Ann Surg Oncol. 2017;24:2915\u20132924.","DOI":"10.1245\/s10434-017-5927-y"},{"key":"3697_CR23","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ejogrb.2022.01.026","volume":"271","author":"M Le Gac","year":"2022","unstructured":"Le Gac M, Dabi Y, Ilenko A, De Foucher T, Ferrier C, Zilberman S, Sussfeld J, Touboul C, Darai E, Bendifallah S. Identification of patients with ductal carcinoma in situ at high risk of postoperative upstaging: A comprehensive review and an external (un)validation of predictive models developed. Eur J Obstet Gynecol Reprod Biol. 2022;271:7\u201314.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"3697_CR24","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1007\/s00520-023-08083-w","volume":"31","author":"DC Guven","year":"2023","unstructured":"Guven DC, Erul E, Kaygusuz Y, Akagunduz B, Kilickap S, De Luca R, Rizzo A. Immune checkpoint inhibitor-related hearing loss: a systematic review and analysis of individual patient data. Support Care Cancer. 2023;31:624.","journal-title":"Support Care Cancer"},{"key":"3697_CR25","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1080\/17425255.2021.2029405","volume":"17","author":"A Rizzo","year":"2021","unstructured":"Rizzo A, Santoni M, Mollica V, Logullo F, Rosellini M, Marchetti A, Faloppi L, Battelli N, Massari F. Peripheral neuropathy and headache in cancer patients treated with immunotherapy and immuno-oncology combinations: the MOUSEION-02 study. Expert Opin Drug Metab Toxicol. 2021;17:1455\u201366.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"3697_CR26","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.2217\/fon-2021-1647","volume":"18","author":"A Rizzo","year":"2022","unstructured":"Rizzo A, Cusmai A, Acquafredda S, Giovannelli F, Rinaldi L, Misino A, Palmiotti G. KEYNOTE-522, IMpassion031 and GeparNUEVO: changing the paradigm of neoadjuvant immune checkpoint inhibitors in early triple-negative breast cancer. Future Oncol. 2022;18:2301\u20139.","journal-title":"Future Oncol"},{"key":"3697_CR27","doi-asserted-by":"publisher","unstructured":"Sahin TK, Rizzo A, Aksoy S, Guven DC. Prognostic Significance of the Royal Marsden Hospital (RMH) Score in Patients with Cancer: A Systematic Review and Meta-Analysis. Cancers (Basel). 2024;16(10):1835. https:\/\/doi.org\/10.3390\/cancers16101835.","DOI":"10.3390\/cancers16101835"},{"key":"3697_CR28","doi-asserted-by":"publisher","first-page":"1362641","DOI":"10.3389\/fonc.2024.1362641","volume":"14","author":"R Caputo","year":"2024","unstructured":"Caputo R, Buono G, Piezzo M, Martinelli C, Cianniello D, Rizzo A, Pantano F, Staropoli N, Cangiano R, Turano S, et al. Sacituzumab Govitecan for the treatment of advanced triple negative breast cancer patients: a multi-center real-world analysis. Front Oncol. 2024;14:1362641.","journal-title":"Front Oncol"},{"key":"3697_CR29","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s10549-023-07097-6","volume":"202","author":"S Sasada","year":"2023","unstructured":"Sasada S, Kondo N, Hashimoto H, Takahashi Y, Terata K, Kida K, Sagara Y, Ueno T, Anan K, Suto A, et al. Prognostic impact of adjuvant endocrine therapy for estrogen receptor-positive and HER2-negative T1a\/bN0M0 breast cancer. Breast Cancer Res Treat. 2023;202:473\u201383.","journal-title":"Breast Cancer Res Treat"},{"key":"3697_CR30","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1148\/radiol.213174","volume":"305","author":"SA Lee","year":"2022","unstructured":"Lee SA, Lee Y, Ryu HS, Jang MJ, Moon WK, Moon HG, Lee SH. Diffusion-weighted Breast MRI in Prediction of Upstaging in Women with Biopsy-proven Ductal Carcinoma in Situ. Radiology. 2022;305:307\u201316.","journal-title":"Radiology"},{"key":"3697_CR31","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/jmri.28539","volume":"58","author":"M Hong","year":"2023","unstructured":"Hong M, Fan S, Yu Z, Gao C, Fang Z, Du L, Wang S, Chen X, Xu M, Zhou C. Evaluating Upstaging in Ductal Carcinoma In Situ Using Preoperative MRI-Based Radiomics. J Magn Reson Imaging. 2023;58:454\u201363.","journal-title":"J Magn Reson Imaging"},{"key":"3697_CR32","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1093\/jbi\/wbad071","volume":"5","author":"KA Hashiba","year":"2023","unstructured":"Hashiba KA, Mercaldo S, Venkatesh SL, Bahl M. Prediction of Surgical Upstaging Risk of Ductal Carcinoma In Situ Using Machine Learning Models. J Breast Imaging. 2023;5:695\u2013702.","journal-title":"J Breast Imaging"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03697-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-03697-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03697-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T03:29:26Z","timestamp":1738726166000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-025-03697-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,5]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3697"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-03697-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4866912\/v1","asserted-by":"object"}]},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,5]]},"assertion":[{"value":"6 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethical Committee for Epidemiology of Hiroshima University (no. E2018-1166) and conducted in accordance with the Declaration of Helsinki and the Ethical Guidelines for Medical Research Involving Human Subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43"}}